2024-11-19 09:32:51
First approval of Cadonilimab (PD-1/CTLA-4 bispecific) published in Drugs, a peer-reviewed medical journal
Corporate/ 2023-07-24
First approval of Cadonilimab (PD-1/CTLA...

HONG KONG,Aug. 26,2022-- Akeso,Inc. (9926.HK) ("Akeso"),a biopharmaceutical company committed to the research,development,manufact...

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference
Health/ 2023-07-22
Kira Pharmaceuticals to Present New Prec...

Oral presentation characterizes promising PK/PD properties of KP104 in relevant animal models and supports its further development as a pote...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release